Autoimmune pancreaitis
Conditions
Interventions
A specific needle (AcquireTM) is used for EUS-guided tissue sampling. Once only.
Sponsors
Nagoya University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients who meet image criteria of AIP on ICDC and have not treated before. (2) Patients between 20 and 80 years old at the time of enrollment. (3) Performance status of 0 to 1. (4) Preservation of main organ functions at the time of diagnosis. (5) Provision of written consent to participate in the study.
Exclusion criteria
Exclusion criteria: (1) Steroid administration within 3 months before the initiation of treatment. (2) Poorly controlled infection (including active tuberculosis). (3) Serious drug allergy. (4) Difficult in observation of the course of endoscopy. (5) Malignant tumor. (6) Serious adverse events. (7) Pregnant and lactating women, women who are possibly pregnant, and women who might want to become pregnant. (8) Severe mental disorder (9) Judgement as being ineligible by the principal or subinvestigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rate of pathological findings which meet level 1 of international consensus diagnostic criteria for AIP (ICDC) by EUS-FNB | — |
Countries
Japan
Contacts
Public ContactTakuya Ishikawa
Nagoya University Graduate School of Medicine Department of Gastroenterology
Outcome results
None listed